Marathon Trading Investment Management LLC Biogen Inc. Transaction History

Marathon Trading Investment Management LLC

  • $201 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$212.02 - $267.71 $636,060 - $803,129
3,000 New
3,000 $646,000
Q4 2020

Feb 16, 2021
SELL
$236.26 - $355.63 $176,013 - $264,944
-745 Closed
0 $0
Q3 2020

Nov 17, 2020
BUY
$264.77 - $305.71 $197,253 - $227,753
745 New
745 $211,000
Q2 2019

Aug 14, 2019
SELL
$219.29 - $241.72 $225,868 - $248,971
-1,030 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$216.71 - $338.96 $223,211 - $349,128
1,030 New
1,030 $243,000

Others Institutions Holding BIIB

# of Institutions
1,035
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email